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Abstract
Background: Retinitis pigmentosa (RP), a clinically and genetically heterogeneous group of retinal
degeneration disorders affecting the photoreceptor cells, is one of the leading causes of genetic
blindness. Mutations in the photoreceptor-specific gene RP1 account for 3–10% of cases of
autosomal dominant RP (adRP). Most of these mutations are clustered in a 500 bp region of exon
4 of RP1.
Methods:  Denaturing gradient gel electrophoresis (DGGE) analysis and direct genomic
sequencing were used to evaluate the 5' coding region of exon 4 of the RP1 gene for mutations in
150 unrelated index adRP patients. Ophthalmic and electrophysiological examination of RP patients
and relatives according to pre-existing protocols were carried out.
Results: Three novel disease-causing mutations in RP1 were detected: Q686X, K705fsX712 and
K722fsX737, predicting truncated proteins. One novel missense mutation, Thr752Met, was
detected in one family but the mutation does not co-segregate in the family, thereby excluding this
amino acid variation in the protein as a cause of the disease. We found the Arg677Ter mutation,
previously reported in other populations, in two independent families, confirming that this
mutation is also present in a Spanish population.
Conclusion: Most of the mutations reported in the RP1 gene associated with adRP are expected
to encode mutant truncated proteins that are approximately one third or half of the size of wild
type protein. Patients with mutations in RP1 showed mild RP with variability in phenotype severity.
We also observed several cases of non-penetrant mutations.
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Background
Retinitis pigmentosa (RP) is a common inherited retinop-
athy that affects more than one million people world-
wide. Clinical findings in RP include night blindness, loss
of peripheral vision and progressive degeneration of the
retina that usually culminates in severe visual impairment
or complete blindness [1]. The disease is characterized by
abnormal or absent responses on electroretinography
(ERG) and is associated with retinal atrophy, bone spi-
cule-like pigmentary deposits and attenuation of retinal
vessels. RP can be inherited in autosomal dominant, auto-
somal recessive, X linked [2-5] or digenic forms [6]. Sev-
eral genes have been identified by linkage studies or
candidate gene screening for each of these RP types [7] ,
although the majority remain unknown [8]. Autosomal
dominant retinitis pigmentosa (adRP) accounts for 25–
30% of all Spanish RP patients (unpublished data). Muta-
tions in genes with specific expression in the retina caus-
ing adRP have been reported [2-8]: rhodopsin (RHO),
peripherin/RDS, NRL, CRX, RP1 and FSCN2 [9]. The
major contribution in a Spanish population is due to rho-
dopsin mutations (19.5 %), with the rest of the specific
genes expressed in the retina less than 4% [unpublished
results] More recently, mutations in the ubiquitously
expressed pre-mRNA splicing factor genes PRPF3, PRPF8,
PRPF31 or in the IMPDH1 gene have also been associated
with adRP [10-13]. The contribution of mutations in these
genes is above 8% in a Spanish population [unpublished
results].
The RP1 gene has been localized to the pericentric region
of chromosome 8 [14]. The RP1 gene has four exons giv-
ing rise to a mRNA of about 7 kb, which is predicted to
encode a protein of 2156 amino acids in length [15-17].
Immunofluorescence analysis carried out in human and
mouse retinas revealed that RP1 proteins are specifically
localized to the connecting cilia of rod and cone photore-
ceptors [18]. Mouse models of the RP1 form of RP have
been generated by targeted disruption of the mouse
ortholog (Rp1) of human RP1. Studies carried out in these
mouse models demonstrate that the Rp1 protein is
required for normal morphogenesis of the photoreceptor
outer segment [19]. Recent studies indicate that RP1 is
required for the correct orientation and higher order
stacking of outer segment discs [20]. Furthermore, the
RP1 protein has been reported as a microtubule-associ-
ated protein (MAP) forming part of the photoreceptor
axoneme [21]
Screening for mutations in RP1 has been carried out in
different adRP populations [22-27]. Most of the muta-
tions in RP1 causing adRP are single nucleotide substitu-
tions that produce a premature stop codon or insertion/
deletion changes predicting a truncated protein [23].
These mutations are mostly located in the 5' coding region
of the 4 kb long exon 4 of the RP1 gene.
Methods
Informed consent was obtained from all subjects who par-
ticipated in the study and the research adhered to the ten-
ets of the Declaration of Helsinki.
Ophthalmological and electrophysiological studies
A complete ophthalmic examination was performed in all
patients. The examination consisted of best corrected vis-
ual acuity with Snellen optotypes, computerised perime-
try (recorded with the OCTOPUS 500) and
biomicroscopy and fundus examination after pupillary
dilatation. Electroretinograms (ERG) were performed
according to the standard testing protocols proposed by
ISCEV [28].
Polymerase Chain Reaction (PCR)
Genomic DNA was prepared from peripheral blood lym-
phocytes using QIAmp DNA Blood Mini Kit (Qiagen,
Valencia, CA). The coding regions of exon 4 of the RP1
gene were amplified using primers (Table 1). One PCR
primer in each pair included a 40-base GC-rich segment
("GC-clamp") attached to its 5' end to facilitate the detec-
tion of mutations by denaturing gradient gel electro-
phoresis (DGGE). PCR reactions were performed in a 50
µl volume of buffer (20 mM Tris-HCl pH 8.55, 16 mM
(NH)2SO4, 1.5 mM MgCl2 150 µg/ml BSA, 10% DMSO)
containing 50–200 ng of human genomic DNA, 25 pico-
mols of each primer, 10 nanomols of each deoxyribonu-
cleoside triphosphate, and 1.5 units of Taq polymerase.
Incubation was performed for 40 cycles consisting of 30
seconds at 94°C, 30 seconds at 58°C and 30 seconds at
Table 1: Primers and DGGE screening conditions
Primers* cDNA Sequence Fragment size (bp) Gradient %** Running T (°C)
Forward 5'-GTAATAACTCTGGAACTGACAA-3' 1998–2308 350 40–70 50
Reverse 5'-GC-GGACTATCTGAACTTTGCACTA-3'
Forward 5'-CAGGTATCAAGATGGACAGC-3' 2197–2461 304 40–70 50
Reverse 5'-GC-TGAACCTTGGAATTTTGAGTAG-3'
* (GC) = 5'-CGCCCGCCGCGCCCCGCGCCCGGCCCGCCGCCCCCGCCCG-3' ** 100% denaturant = 7M urea and 40% (v/v) formamide in 
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72°C; followed by 5 minutes at 94°C and 5 minutes at
72°C. Electrophoresis of 8 µl of final PCR reaction vol-
ume was performed on 1.5% agarose gel to test the ampli-
fication reaction.
Mutation detection
Mutation analysis of the coding region of exon 4 of the
RP1 gene was carried out by DGGE [29,30]. Table 1 shows
the electrophoretic conditions, including the running
temperature and the denaturing gradient of the forma-
mide/urea concentration range for each different PCR
product. The DNA from the PCR fragment containing the
R677X mutation was digested with the endonuclease TaqI
(Roche, Barcelona, Spain), according to the manufac-
turer's specifications. For DNA sequencing, PCR products
were purified using the QIAquick Gel Extraction Purifica-
tion Kit (Qiagen). DNA sequencing was carried out using
the OpenGene automated DNA sequencing system from
Visible Genetics and Thermo Sequenase Cy5.5 Dye Termi-
nator Cycle Sequencing Kit (Amersham Pharmacia Bio-
tech, Barcelona, Spain).
Table 2: Mutations detected in the Spanish adRP families
Exon DNA change Mutation Symptomatic carriers Asymptomatic carriers Total carriers
4 2177 C > T (CGA→TGA) Arg677Ter 5 3 8
4 2204C > T (CAA→TAA) Gln686Ter 2 2 4
4 2263delA Lys705fsX712 6 5 11
4 2313delAAinsG Lys722fsX737 3 3 6
4 2403C > T (ACG→ATG) Thr752Met* 1 - 1
*This mutation does not appear to be pathogenic.
Table 3: Clinical features of Spanish families with RP1 mutations
Mutation Family 
members
Age 
(years)
Onset of 
NB
Onset 
↓VFC
Onset 
↓VA
Current 
VF
Current 
VA
Current 
ERG
Funduscopy
K722fsX737 I-1 85 60 65 None Not done Not done Not done Typical RP
II-2 59 50 49 None 10°central 0.6 BE Not 
detectable
Typical RP
II-3 58 43 46 50 10°central < < 0.1 BE Not 
detectable
Typical RP + 
CME
II-4 56 37 54 None 10°central 0.5 BE Not 
detectable
Typical RP
Q686X I-1 83 69 74 69 10°central 0.2 BE R/M nd. & ↓↓ Typical RP
II-1 60 None None None Normal 1.0 BE Normal Normal
II-6 54 30 45 25 10°central 0.3 BE R/M & ↓↓ C 
N
Typical RP
III-6 29 None None None Normal 1.0 BE Normal Normal
III-7 26 None None None Normal 1.0 BE Normal Normal
K705fsX712 II-1 73 None None None PC up VF 0.7/0.6 R nd & M/C↓ Normal
III-1 46 Unknown Unknown Unknown PC Not done Not done Typical RP
III-3 42 30 35 None 20°R/10°L 0.8/1 Not 
detectable
Typical RP
III-4 40 None None None Normal 1.0 BE Normal Normal
III-5 39 None None None Normal 1.0 BE Normal Normal
III-6 49 Unknown Unknown Unknown PC Not done Not done Typical RP
III-11 41 None None None Normal 1.0 BE Normal Normal
III-12 38 Unknown Unknown Unknown PC Not done Not done Typical RP
III-14 39 None None None Normal 1.0 BE Normal Normal
IV-1 11 None None None Normal 1.0 BE Normal Normal
BE: Both Eyes; ERG: Electroretinogram; CME: Cystoid Macular edema; NB: Night blindness; PC upVF: Peripheral constriction of upper visual field; R nd & M/
C↓: Not detectable rod responses, impaired amplitude and delayed response of mixed and cones; R/M ↓↓ & C N: Impaired amplitude and delayed response 
of rods and mixed, normal cone response; R/M nd. & C↓↓: Not detectable rod and mixed responses, impaired amplitude and delayed response of cones; 
Typical RP: Pale discs, attenuated vessels, bone-spicule intraretinal pigmentation; VA: Visual acuity; VF: Visual field; VFC: Visual field constriction.BMC Medical Genetics 2006, 7:35 http://www.biomedcentral.com/1471-2350/7/35
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Results
We screened Spanish families with adRP for mutations
between c-DNA positions 1998 and 2639 (GenBank:
AF141021) in exon 4 of the RP1 gene. Three PCR-ampli-
fied fragments from DNA of the 150 index patients of
adRP Spanish families and 100 controls were analyzed by
DGGE. Five different electrophoretic patterns were identi-
fied. Direct DNA sequencing revealed four mutations that
predict truncated proteins and one missense mutation,
Thr752Met (Table 2). These sequence changes were not
observed in the controls. The common mutation
Arg677Ter was detected in two index cases. Because this
mutation abolishes the TaqI endonuclease restriction site,
restriction analysis was performed in the members of
these two families (Figure 1A). Co-segregation analysis
carried out in the adRP families demonstrated that the
four mutations generating truncated proteins were carried
by all the affected members of the family (Figures 1 and
Table 4: ERG values of Spanish families with RP1 mutations
RODS MIXED (ROD-CONES) CONOS 30 Hz Flicker
INDIVI
DUAL
EYE b-wave 
AMPL.
b-wave 
IMP.T
a-wave 
AMPL
a-wave 
IMP.T.
b-wave 
AMPL.
b-wave 
IMP.T
b-wave 
AMP.
b-wave 
IMP.T
b-wave 
AMPL
b-wave 
IMP.T
Q686X
I-1 R ND ND ND ND ND ND 50 36 NV NV
L N DN DN DN DN DN D 3 0 3 7 N VN V
II-1 R 260 109 378 23 874 49 218 30 131 29
L 230 105 363 23 833 48 238 31 144 29
I I - 6 R N DN DN DN DN DN DN DN DN DN D
L N DN DN DN DN DN DN DN DN DN D
III-6 R 110 93 158 22 389 44 142 31 97 27
L 157 108 213 22 441 44 140 31 65 25
III-7 R 116 99 197 22 491 45 154 30 68 27
L 1 3 79 41 7 02 24 1 24 5N VN VN VN V
K705fsX
712
II-1 R ND ND 39 24 267 49 85 34 38 32
L ND ND 51 26 246 52 76 35 63 33
I I I - 1 R----------
L----------
I I I - 3 R N DN DN DN DN DN DN DN DN DN D
L N DN DN DN DN DN DN DN DN DN D
III-4 R 177 93 198 21 492 51 198 29 148 27
L 187 93 199 21 527 49 230 30 122 27
III-5 R 186 104 221 22 556 47 166 30 58 28
L 209 109 219 21 500 47 168 30 75 28
I I I - 6 R----------
L----------
III-11 R 165 103 274 22 500 46 101 32 77 30
L 169 106 299 23 563 46 104 31 83 29
I I I - 1 2R----------
L----------
III-14 R 170 100 266 21 705 49 207 29 127 29
L 166 103 195 21 570 48 204 29 100 29
IV-1 R 106 86 150 21 393 45 152 29 64 26
L 138 91 191 21 491 46 193 29 80 27
K722fsX
737
I - 1 R----------
L----------
II-2, II-3, 
II-4
R N DN DN DN DN DN DN DN DN DN D
L N DN DN DN DN DN DN DN DN DN D
ND: Not detectable; NV: Not valid; -:Not done or not availableBMC Medical Genetics 2006, 7:35 http://www.biomedcentral.com/1471-2350/7/35
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2). However, the missense mutation Thr752Met was not
carried by several RP patients, though it was present in
some unaffected individuals of the family (data not
shown). The two frameshift mutations, 2263delA and
2313delAAinsG produce 7 and 15 altered codons respec-
tively, before a premature stop. The Spanish families with
adRP caused by mutations in the RP1 gene showed a mild
form of RP. Affected members of these families generally
had a late onset of night blindness and slow loss of visual
acuity and visual fields (Table 3). ERGs of the patients
Table 5: Normal values of ERG
RODS MIXED (ROD-CONES) CONOS 30 Hz Flicker
b-wave 
AMPL.
b-wave 
IMP.T.
a-wave 
AMPL.
a-wave 
IMP.T.
b-wave 
AMPL.
b-wave 
IMP.T.
b-wave 
AMP.
b-wave 
IMP.T.
b-wave 
AMPL.
b-wave 
IMP.T.
100 – 350 70 – 110 150 – 360 25 – 30 380 – 750 35 – 55 85 – 225 26 – 31 20 – 140 24 – 35
AMPL. (Amplitude) = µV IMP.T. (Implicit Time) = ms
Intrafamilial variability of disease expression in the K705fsX712 RP1 mutation Figure 3
Intrafamilial variability of disease expression in the K705fsX712 RP1 mutation. A. Visual field tests recorded in a 
normal individual, patient II-1 at the age of 72 years and III-3 at the age of 40, carrying the mutation. B. Electroretinographic 
recording in a normal individual and in patient II-1 at the age of 72 years still showing response of the rods and cones while in 
patient III-3 the ERG was abolished (not shown).
                         
                                                            
           
       
       
NORMAL  
     II-1
     III-3
  NORMAL 
B  A
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Mutation in the RP1 gene due to nucleotide substitution Figure 1
Mutation in the RP1 gene due to nucleotide substitution. A. Pedigree, restriction analysis, and direct sequencing of 
Spanish families showing the R677X mutation. The 2177 C→T substitution abolishes the TaqI restriction site. M is the DNA 
marker consisting of a 100 bp ladder and U/D is the undigested DNA PCR fragment. B. Pedigree, DGGE and direct sequencing 
of the family carrying the Q686X mutation in the RP1 gene. Affected individuals, asymptomatic carriers and non-carriers of the 
mutation are represented by solid symbols, symbols with an internal dot and open symbols, respectively.
A      2177 C→T (R677X) 
     
    1   1    2    1    2   3  U/D M         1     2     3    1    2    3    4    5    6   M  U/D     
  I      II            III           II      III                     IV
B      2204  C→T (Q686X) 
    1   1    2    3    4    5    6    7   1    2    3    4    5    6    7    
      I                    II                                      III                     
5
1
12 3 4 6 7
1 2 3 45 67
I
II
III
M/wt
M/wt wt/wt wt/wt wt/wt wt/wt M/wt wt/wt
wt/wt wt/wt wt/wt wt/wt wt/wt M/wt M/wt
I
II
III
IV
V
1 23
1
1 2 3 45 6
M/wt
M/wt M/wt
M/wt M/wt M/wt M/wt wt/wt M/wt
I
II
III
1
12
123
wt/wt
wt/wt M/wt
wt/wt wt/wt M/wtBMC Medical Genetics 2006, 7:35 http://www.biomedcentral.com/1471-2350/7/35
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Mutation in the RP1 gene by A deletions Figure 2
Mutation in the RP1 gene by A deletions. Pedigree, DGGE and direct sequencing of Spanish families showing K705fsX712 
(A) and K722fsX737 (B) in the RP1 gene. Affected individuals, asymptomatic carriers and non-carriers of the mutation are 
represented by solid symbols, symbols with an internal dot and open symbols, respectively.
A      2263delA (K705fsX712) 
  1      2    1      2      3     4     5     6     7     8      9    10   11   12   13   14   15    16   17    1     2     3      4  
    II                                                             III                                                                           IV 
B     2313delAAinsG  (K722fsX737) 
                1     1     2     3     4     5    6     1     2     3    4
                                I                      II                             III 
1
1 2 3 4 5 6
1 23 4
I
II
III
IV
M/wt
wt/wt M/wt M/wt M/wt wt/wt M/wt
M/wt M/wt wt/wt wt/wt
12
1 2 3 45
1 2
6 7 8 91 0 11 12
3 4
13 14 15 16 17
I
II
III
IV
M/wt wt/wt
M/wt wt/wt M/wt M/wt M/wt M/wt wt/wt wt/wt wt/wt wt/wt M/wt M/wt wt/wt M/wt wt/wt wt/wt wt/wt
M/wt wt/wt M/wt wt/wtBMC Medical Genetics 2006, 7:35 http://www.biomedcentral.com/1471-2350/7/35
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were usually abolished (Tables 4 and 5) but in some indi-
viduals, even at an advanced age, a diminished signal was
recordable (Figure 3). This mild clinical expression may
explain the familial heterogeneity and the fact that nearly
half of the individuals with a mutation in RP1 were
asymptomatic (Table 2). Furthermore, incomplete pene-
trance previously reported in RP1 forms could also be
present in these families (Figures 1 and 2).
Discussion
Mutations in the RP1 gene account for 5–10% of adRP in
American and British populations [24]. RP1 is the second
most frequently mutated gene causing adRP, the first
being rhodopsin (20–25% of cases). Most disease-causing
mutations in the RP1 gene are predicted to give rise to a
truncated protein. These mutations tend to be clustered in
a region within the first third of exon 4 of the RP1 gene,
suggesting that truncation of the extreme C-terminal end
of the RP1 protein does not cause adRP.
Except for a few missense mutations of uncertain patho-
genicity, the dominant mutations in the RP1 gene have
been found in a region extending from codons 658 to
1053 in exon 4, although most are clustered between
codons 658–872 [24]. These mutations are mainly single
nucleotide changes, insertion or deletion sequences lead-
ing to premature stop codons that presumably encode
truncated proteins of approximately one third the length
of the wild type protein [22-27]. We screened for muta-
tions within the region extending from codons 616–879
in exon 4 of the RP1 gene in Spanish families with adRP.
By only screening part of the RP1 gene, we are probably
missing novel mutations in other parts of the gene, which
may underestimate the total contribution of RP1 to adRP
in the Spanish population analyzed.
Four disease-causing mutations in the RP1 gene were
found in five of 150 (3.5%) adRP families. The Arg677Ter
mutation was detected in two unrelated families. This
mutation has been reported in apparently independent
families from British, Chinese and North American popu-
lations [17,18,26] suggesting a hotspot mutation. Geno-
type analysis showed no linkage between the two Spanish
families carrying the Arg677Ter mutation, supporting the
suggestion that this mutation is a hotspot rather than an
ancestral mutation in the RP1 gene [23]. Further support
for this hotspot hypothesis was recently provided in a
report of a de novo Arg677Ter RP1 mutation [31]. The
mutations in the RP1 gene associated with adRP which we
found in the Spanish population are expected to result in
premature termination of the protein. Two types of muta-
tions in the RP1 sequence were found. One mutation was
produced by a single nucleotide change C to T leading to
a premature stop codon (Figure 1). The second type was
due to insertion or deletion of nucleotides in regions with
multiple series of A residues in the DNA sequence of the
RP1 gene (Figure 2). These sequences could cause DNA
slippage due to mismatch of the two DNA strands during
replication, thereby generating mutations [32]. This
mechanism could explain the clustered mutations in a
region rich in series of A sequences within exon 4 of RP1
which result in truncated mutant proteins.
Nonsense mutations in mammalian genes generally lead
to unstable mRNA molecules with very little or no trans-
lated protein [33]. However, this mechanism seems to be
less probable for the nonsense mutations in the last exon
of the gene [33]. This is the case in the RP1 mutations in
exon 4, which are probably translated as truncated pro-
teins. Recent experiments using lymphoblastoid cell lines
from patients with the Arg677Ter mutation in illegitimate
transcription assays detected mRNA carrying the
Arg677Ter mutation [20] , suggesting that truncated RP1
proteins may be produced in the retina. Thus, the trun-
cated proteins generated in the RP1 mutants may exert a
deleterious effect on the photoreceptor cell. However,
studies carried out in murine models with Rp1 truncated
proteins showed that these proteins appear to be non-
functional and do not seem to exert a dominant negative
effect in heterozygous mice [20].
Sequence variations have also been detected in the screen-
ing of the RP1 gene. Most of the missense mutations
reported in the RP1 gene do not cause adRP [24]. We
detected the Thr752Met mutation in one adRP family.
This mutation was not detected in two RP patients but it
was present in unaffected members of the family. Further-
more, the clinical RP phenotype of the affected members
of this family resulted in a more severe disease expression
than in the patients with RP caused by a mutation in the
RP1 gene. The Thr752Met mutation is unlikely, therefore,
to be associated with adRP.
Recent studies using murine models of RP have contrib-
uted to the understanding of the function of the Rp1 pro-
tein [19-21]. The Rp1 protein is required in normal
morphogenesis and in the correct stacking of the outer
segment discs of the photoreceptors. The Rp1 protein may
also play a role in the transport of rhodopsin to the outer
segments [18,19]. The N-terminus of the human RP1 pro-
tein shares significant homology with doublecortin
(DCX), a mutant of which is involved in a cerebral cortex
abnormality [34]. The DCX region homologous to RP1 is
known to interact with microtubules [35]. Recently, RP1
has also been shown to be a microtubule-associated pro-
tein forming part of the larger class of MAP proteins,
whose dysfunction is associated with degenerative dis-
eases [21].BMC Medical Genetics 2006, 7:35 http://www.biomedcentral.com/1471-2350/7/35
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The mutations detected in RP1 patients probably generate
a deficiency in the function of RP1 in the retina. The
majority of the patients who are heterozygous for the RP1
mutation show a type 2 autosomal dominant RP pheno-
type, with a relatively late onset of night blindness by the
third or fourth decade of life [24,25]. Patients who are
homozygous for a mutation in RP1, however, show a
more severe RP phenotype [16]. Nevertheless, considera-
ble variation may exist within the same family in the age
at which the clinical disease is manifested. In some of the
Spanish families we detected asymptomatic carriers of
mutations in RP1 (Figure 4) whereas younger siblings
were affected. Some of these asymptomatic individuals
carrying the mutation even showed a normal or near nor-
mal ERG in the third or fourth decade of life. In such adRP
families with late onset or slow degeneration, screening
for mutations in all at-risk members would seem essen-
tial.
Conclusion
In conclusion, the contribution to adRP of RP1 mutations
detected in the clustered mutation region of the RP1 gene
associated with adRP was 3.3% in a Spanish population.
We also detected the common mutation Arg677Ter,
which has been reported in other ethnic groups. The indi-
viduals carrying mutations in the RP1 gene showed a mild
RP phenotype with late onset of the disease or even
remaining asymptomatic, suggesting incomplete pene-
trance in some families. All the mutations detected in the
RP gene associated with ADRP are expected to encode
truncated proteins.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MJG, MMG and IH carried out the molecular genetic anal-
ysis, were involved in drafting the manuscript and revised
the paper. MM and BGS were involved in ophthalmic
examination of the patients. CA, GA anb MB contributed
to the clinical genetic classification of the patients and
families, and provided the DNA samples. MC contributed
to conception and design of the study, analysed and inter-
preted data and wrote the paper.
Acknowledgements
We thank the families for their participation in this research and Ian John-
stone for the English editing of the manuscript. We also thank S. Jacobson 
for the critical revision of the text. This work was partially supported by 
grants from the Fondo de Investigaciones Sanitarias (FIS, 01/0081-01, G03/
018) and the Fundación ONCE.
References
1. Berson EL: Retinitis Pigmentosa.  Invest Ophthalmol Vis Sci 1993,
34:1659-1676.
2. Humphries P, Kenna P, Farrar GJ: On the molecular genetics of
retinitis pigmentosa.  Science 1992, 256:804-808.
3. Dryja T, Li T: Molecular genetics of retinitis pigmentosa.  Hum
Mol Genet 1995, 4:1739-43.
4. Wang Q, Chen Q, Zhao K, Wang L, Wang L, Traboulsi EI: Update
on the molecular genetics of retinitis pigmentosa.  Ophthalmic
Genet 2001, 22:133-154.
5. Farrar GJ, Kenna PF, Humphries P: On the genetics of retinitis
pigmentosa and on mutation-independent approaches to
therapeutic intervention.  EMBO J 2002, 21(5):857-864.
Intrafamilial variability of disease expression in the Q686X RP1 mutation Figure 4
Intrafamilial variability of disease expression in the Q686X RP1 mutation. Comparison of visual field test and ocular 
fundus of patient II-6 with the asymptomatic III-6 member of the family, both carrying the mutation in the RP1 gene.
                      
II-6, age 52   III-6, age 28  Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Genetics 2006, 7:35 http://www.biomedcentral.com/1471-2350/7/35
Page 10 of 10
(page number not for citation purposes)
6. Kajiwara K, Berson EL, Dryja TP: Digenic retinitis pigmentosa
due to mutations at the unlinked peripherin/RDS and ROM1
loci.  Science  1994, 264(5165):1604-1608.
7. Retinal Information Network   [http://www.sph.uth.tmc.edu/Ret
net]
8. Rivolta C, Sharon D, DeAngelis MM, Dryja TP: Retinitis pigmen-
tosa and allied diseases: numerous diseases, genes and inher-
itance patterns.  Hum Mol Genet 2002, 11(10):1219-1227. Review.
Erratum in: Hum Mol Genet 2003, 1: 12(5):583-584.
9. Wada Y, Abe T, Takeshita T, Sato H, Yanashima K, Tamai M: Muta-
tion of human retinal fascin gene (FSCN2) causes autosomal
dominant retinitis pigmentosa.  Invest Ophthalmol Vis Sci 2001,
42(10):2395-2400.
10. Vithana EN, Abu-Safieh L, Allen MJ, Carey A, Papaioannou M,
Chakarova C, Al-Maghtheh M, Ebenezer ND, Willis C, Moore AT,
Bird AC, Hunt DM, Bhattacharya SS: A human homolog of yeast
pre-mRNA splicing gene, PRP31, underlies autosomal dom-
inant retinitis pigmentosa on chromosome 19q13.4 (RP11).
Mol Cell 2001, 8(2):375-381.
11. McKie AB, McHale JC, Keen TJ, Tarttelin EE, Goliath R, van Lith-Ver-
hoeven JJ, Greenberg J, Ramesar RS, Hoyng CB, Cremers FP, Mackey
DA, Bhattacharya SS, Bird AC, Markham AF, Inglehearn CF: Muta-
tions in the pre-mRNA splicing factor gene PRPC8 in auto-
somal dominant retinitis pigmentosa (RP13).  Hum Mol Genet
2001, 10(15):1555-1562.
12. McKie AB, McHale JC, Keen TJ, Tarttelin EE, Goliath R, van Lith-Ver-
hoeven JJ, Greenberg J, Ramesar RS, Hoyng CB, Cremers FP, Mackey
DA, Bhattacharya SS, Bird AC, Markham AF, Inglehearn CF: Muta-
tions in PRPF3, a third member of pre-mRNA splicing factor
genes, implicated in autosomal dominant retinitis pigmen-
tosa.  Hum Mol Genet 2002, 11:87-92.
13. Kennan A, Aherne A, Palfi A, Humphries M, McKee A, Stitt A, Simp-
son DA, Demtroder K, Orntoft T, Ayuso C, Kenna PF, Farrar GJ,
Humphries P: Identification of an IMPDH1 mutation in auto-
somal dominant retinitis pigmentosa (RP10) revealed fol-
lowing comparative microarray analysis of transcripts
derived from retinas of wildtype and Rho-/- mice.  Hum Mol
Genet 2002, 11:547-558.
14. Blanton SH, Heckenlively JR, Cottingham AW, Friedman J, Sadler LA,
Wagner M, Friedman LH, Daiger SP: Linkage mapping of auto-
somal dominant retinitis pigmentosa (RP1) to the pericen-
tric region of human chromosome 8.  Genomics 1991,
11(4):857-869.
15. Sullivan LS, Heckenlively JR, Bowne SJ, Zuo J, Hide WA, Gal A, Den-
ton M, Inglehearn CF, Blanton SH, Daiger SP: Mutations in a novel
retina-specific gene cause autosomal dominant retinitis pig-
mentosa.  Nat Genet 1999, 22(3):255-259.
16. Pierce EA, Quinn T, Meehan T, McGee TL, Berson EL, Dryja TP:
Mutations in a gene encoding a new oxygen-regulated pho-
toreceptor protein cause dominant retinitis pigmentosa.  Nat
Genet 1999, 22(3):248-254.
17. Guillonneau X, Piriev NI, Danciger M, Kozak CA, Cideciyan AV,
Jacobson SG, Farber DB: A nonsense mutation in a novel gene
is associated with retinitis pigmentosa in a family linked to
the RP1 locus.  Hum Mol Genet 1999, 8(8):1541-1546.
18. Liu Q, Zhou J, Daiger SP, Farber DB, Heckenlively JR, Smith JE, Sulli-
van LS, Zuo J, Milam AH, Pierce EA: Identification and subcellular
localization of the RP1 protein in human and mouse pho-
toreceptors.  Invest Ophthalmol Vis Sci 2002, 43(1):22-32.
19. Gao J, Cheon K, Nusinowitz S, Liu Q, Bei D, Atkins K, Azimi A, Daiger
SP, Farber DB, Heckenlively JR, Pierce EA, Sullivan LS, Zuo J: Pro-
gressive photoreceptor degeneration, outer segment dys-
plasia, and rhodopsin mislocalization in mice with targeted
disruption of the retinitis pigmentosa-1 (Rp1) gene.  Proc Natl
Acad Sci U S A 2002, 99(8):5698-5703.
20. Liu Q, Lyubarsky A, Skalet JH, Pugh EN Jr, Pierce EA: RP1 is
required for the correct stacking of outer segment discs.
Invest Ophthalmol Vis Sci 2003, 44(10):4171-4183.
21. Liu Q, Zuo J, Pierce EA: The retinitis pigmentosa 1 protein is a
photoreceptor microtubule-associated protein.  J Neurosci
2004, 24(29):6427-6436.
22. Bowne SJ, Daiger SP, Hims MM, Sohocki MM, Malone KA, McKie AB,
Heckenlively JR, Birch DG, Inglehearn CF, Bhattacharya SS, Bird A,
Sullivan LS: Mutations in the RP1 gene causing autosomal
dominant retinitis pigmentosa.  Hum Mol Genet 1999,
8:2121-2128.
23. Payne A, Vithana E, Khaliq S, Hameed A, Deller J, Abu-Safieh L, Ker-
mani S, Leroy BP, Mehdi SQ, Moore AT, Bird AC, Bhattacharya SS:
RP1 protein truncating mutations predominate at the RP1
adRP locus.  Invest Ophthalmol Vis Sci 2000, 41(13):4069-4073.
24. Berson EL, Grimsby JL, Adams SM, McGee TL, Sweklo E, Pierce EA,
Sandberg MA, Dryja TP: Clinical features and mutations in
patients with dominant retinitis pigmentosa-1 (RP1).  Invest
Ophthalmol Vis Sci 2001, 42(10):2217-2224.
25. Jacobson SG, Cideciyan AV, Iannaccone A, Weleber RG, Fishman GA,
Maguire AM, Affatigato LM, Bennett J, Pierce EA, Danciger M, Farber
DB, Stone EM: Disease expression of RP1 mutations causing
autosomal dominant retinitas pigmentosa.  Invest Ophthalmol
Vis Sci 2000, 41(7):1898-1908.
26. Baum L, Chan WM, Yeung KY, Lam DS, Kwok AK, Pang CP: RP1 in
Chinese: Eight novel variants and evidence that truncation of
the extreme C-terminal does not cause retinitis pigmentosa.
Hum Mutat 2001, 17(5):436.
27. Pang CP, Lam DS: Differential occurrence of mutations causa-
tive of eye diseases in the Chinese population.  Hum Mutat
2002, 19(3):189-208.
28. Marmor MF, Arden GF, Nilsson SE, Zrenner E: Standard for clini-
cal electrophisiology.  Arch Opthalmol 1989, 107:816-819.
29. Sheffield VC, Cox DR, Lerman LS, Myers RM: Attachment of a 40-
base-pair G + C-rich sequence (GC-clamp) to genomic DNA
fragments by the polymerase chain reaction results in
improved detection of single-base changes.  Proc Natl Acad Sci
U S A 1989, 86(1):232-236.
30. Myers RM, Maniatis T, Lerman LS: Detection and localization of
single base changes by denaturing gradient gel electrophore-
sis.  Methods Enzymol 1987, 155:501-527.
31. Schwartz SB, Aleman TS, Cideciyan AV, Swaroop A, Jacobson SG,
Stone EM: De novo mutation in the RP1 gene (Arg677ter)
associated with retinitis pigmentosa.  Invest Ophthalmol Vis Sci
2003, 44(8):3593-3597.
32. Scriver CR, Beaudett AL, Sly WS, Valle D: The metabolic and molecular
bases of inherited disease 7th edition. New York: McGraw-Hill;
1995:259-291. 
33. Hentze MW, Kulozik AE: A perfect message: RNA surveillance
and nonsense-mediated decay.  Cell 1999, 96(3):307-310.
34. Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I,
Cooper EC, Dobyns WB, Minnerath SR, Ross ME, Walsh CA: Dou-
blecortin, a brain-specific gene mutated in human X-linked
lissencephaly and double cortex syndrome, encodes a puta-
tive signaling protein.  Cell 1998, 92(1):63-72.
35. Gleeson JG, Lin PT, Flanagan LA, Walsh CA: Doublecortin is a
microtubule-associated protein and is expressed widely by
migrating neurons.  Neuron 1999, 23(2):257-271.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2350/7/35/prepub